Member Voice

Have Something to Share?

CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website.

Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.

Search

Search
Contributors
  • ACROBiosystems (1)
  • Algen Biotechnologies (1)
  • Argenx (1)
  • Avance Clinical (4)
  • Biointron (3)
  • Brainstorm Therapeutics (1)
  • Centogene (4)
  • CleanSpace (8)
  • Digital Science (3)
  • Encellin (1)
  • Fauna Bio (1)
  • Fenix Group (1)
  • Flannery Sales Systems (5)
  • GeneFab (1)
  • GO-Biz (2)
  • Halloran (1)
  • Hogan Lovells Cadwalader (1)
  • HOPO Therapeutics (1)
  • iNFixion Biosciences (1)
  • Inflammatix (1)
  • MabPlex (4)
  • MBC BioLabs (5)
  • Medscape (6)
  • Nucleus Biologics (2)
  • Nutromics (2)
  • o2h Discovery (2)
  • Oncotelic (1)
  • OPM Biosciences (1)
  • Otsuka (1)
  • ProBio (1)
  • Raydient Oximetry (1)
  • Royale International (8)
  • Sift Biosciences (1)
  • Siolta Therapeutics (1)
  • Slingshot Biosciences (1)
  • SU Group (1)
  • TippingPoint Biosciences (1)
  • Unnatural Products (1)
  • Voro Therapeutics (1)
  • WACKER (2)
  • X-Therma (1)
Member Voice

Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead Slingshot Bio into Its Next Chapter

Slingshot Biosciences

Slingshot Biosciences, a leader in precision-engineered cell mimics for flow cytometry, announced that Dr. Nimisha Srivastava has been appointed Chief...

Industry

iNFixion seeks NF1 treatment by enhancing what the body is doing right

iNFixion Biosciences

Since discovering his daughter’sNF1, a rare disease impacting 1 in 3000 people, nearly 25 years ago, Sarnoff has slowly transformed...

Industry

BrainStorm Therapeutics combines brain organoids and AI for CNS drug discovery

Brainstorm Therapeutics

Artificial intelligence is opening new possibilities for drug discovery. But in neuroscience, AI is only as powerful as the biological...

Member Voice

Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment

Otsuka

Otsuka Pharmaceutical Development & Commercialization, Inc. and Ionis Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 FUSION...

Member Voice

Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio

Medscape

In celebration of Health Simulation Week (September 14-18), we are excited to introduce the Clinical Readiness Studio (CRS), an AI-augmented...

Member Voice

OPM Biosciences Launches Integrated Cell Culture Media-to-Manufacturing Platform for Biosimilar Development

OPM Biosciences

OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform...

Member Voice

Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy

Avance Clinical

Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing international biotechs, today announced the appointment of Tim...

Member Voice

ACROBiosystems Announces Scientific Leadership Award

ACROBiosystems

The Scientific Leadership Award accelerates breakthroughs in cell and gene therapies, in vivo therapeutics, and stem cell research by investing...

Member Voice

Tactical Execution of Commercial Strategy (TECS) in Life Sciences Sales

Flannery Sales Systems

In today’s competitive market, a well-defined commercial strategy is essential for achieving long-term success in sales. But what separates high-performing...

Have Something to Share?

CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website.

Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.

Content Archive